- Home
- CZFS vs CANF Comparison
CZFS vs CANF Comparison
Compare CZFS & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | CANF |
|---|---|---|
| Founded | 1984 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.6M | 3.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CZFS | CANF |
|---|---|---|
| Price | $64.68 | $4.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9,750.00 |
| AVG Volume (30 Days) | 9.5K | ★ 555.2K |
| Earning Date | 01-30-2026 | 02-03-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | ★ 24.64 | N/A |
| EPS | ★ 7.10 | N/A |
| Revenue | ★ $107,399,000.00 | $560,000.00 |
| Revenue This Year | N/A | $461.72 |
| Revenue Next Year | $6.27 | N/A |
| P/E Ratio | $8.84 | ★ N/A |
| Revenue Growth | ★ 9.73 | N/A |
| 52 Week Low | $49.96 | $3.36 |
| 52 Week High | $65.80 | $46.60 |
Technical Indicators
Market Signals| Indicator | CZFS | CANF |
|---|---|---|
| Relative Strength Index (RSI) | 70.80 | 72.72 |
| Support Level | $59.60 | $4.01 |
| Resistance Level | $65.00 | $4.43 |
| Average True Range (ATR) | 2.27 | 0.31 |
| MACD | 0.58 | 0.18 |
| Stochastic Oscillator | 94.42 | 80.99 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.